Embellence Group

Embellence Group

Sälj aktien Köp aktien Handla aktien direkt på nordnet

« Tillbaka

Embellence Group - Broad progress in the DTC strategy

21 juli 2026

  • Net sales -6% y-o-y, EBITA -13% y-o-y
  • Strategic staffing-up now in comps, DTC progressing well
  • We trim our fair value range to SEK 35-42 (36-43)

A perfect storm hit in Q2, but subsiding in H2

Embellence's Q2 contained several, but separate, issues operationally. Cole & Son was still weighed down by the same changes to its sales operations as were discussed in Q1, for net sales growth of -12% in this segment. The group CEO said he expected the previous changes to Cole & Son's setup to have a positive impact in H2. Wall & Decò underperformed through net sales growth of -14%, as far as we understand it due to issues with the sales operations. The group is now reallocating sales and marketing efforts to turn this trend. Lastly, Artscaped faced a very tough comparable quarter, and grew -20%. Driven by these factors, group net sales declined 6% y-o-y despite strong performances by Pappelina and Borås Tapetfabrik. Gross margins improved 80bp y-o-y driven by DTC making up a larger share of the mix, which partly offset the negative scale on opex for a Q2 EBITA margin of 12.6%, -1pp y-o-y. The EBITA comps become easier from Q3'26, as recruiting to drive DTC will mostly be in the comps.

All brands grew DTC sales by double-digits

During the report presentation, the group CEO said all group brands grew their DTC sales by (at least) "double-digits". Pappelina, which we argue has the best product-channel fit, grew DTC sales by 130% y-o-y. Boråstapeter, the largest brand, updated its website in April, and in the next few quarters this is a key area to focus on for us.

We trim our fair value range to SEK 35-42

As we cut '26e/'27e EBITA by 2%/2%, we trim our fair value range to SEK 35-42 (36-43). The share is currently trading at 7x/6x/5x EV/EBITA '26e/'27e/'28e, compared to a historical trading range of 7x-8x NTM and a Swedish peer group of home improvement companies at a median 12x/10x on '26e/'27e. We estimate an 11-13% FCF yield for '26e/'27e, and a dividend yield of 6%.

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-08-25 Isofol Medical - Maximising the dose before Phase 2 Isofol Medical Analys
2026-08-24 Skolon - Broad-based growth continues Skolon Analys
2026-08-24 Gentoo Media - FCF generation remains top priority Gentoo Media Analys
2026-08-24 Impact Coatings - Backlog to carry H2e Impact Coat.. Analys
2026-08-24 I-tech - Beyond a single molecule I-tech Analys
2026-08-23 Catella - Signs of improvement, but delivery stil... Catella Analys
2026-08-23 Ogunsen - Some signs of stabilisation Ogunsen Analys
2026-08-21 Clavister - Strong quarter strengthens the outlook Clavister Analys
2026-08-21 Generic - Investing while growing Generic Analys
2026-08-21 Impact Coatings - A quarter driven by Coating Ser... Impact Coat.. Analys
2026-08-21 Skolon - Sweden profitability gains continue Skolon Analys
2026-08-21 I-tech - Strongest quarter on record I-tech Analys
2026-08-20 Tempest Security - Patrols below plan Tempest Sec.. Analys
2026-08-20 Tempest Security - Progress made but expectations... Tempest Sec.. Analys
2026-08-20 Ascelia Pharma - Still alive: Fighting to reverse... Ascelia Pharma Analys
2026-08-20 Clavister - Defence drives record quarter Clavister Analys
2026-08-20 Catella - Q2 softer than expected, but underlying... Catella Analys
2026-08-20 Generic - Volumes continue to grow Generic Analys
2026-08-19 SinterCast - Past the trough, but recovery pace u... SinterCast Analys
2026-08-19 Xplora Technologies - EBITDA -13% on soft senior ... Xplora Tech.. Analys